Sign in
TVGN Stock Price, Chart, Stats & News
Tevogen Bio Holdings Inc.
Save
41.43M
Market cap
–
Current P/E
–
Forward P/E
TVGN chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -686.47% |
ROE | 389.21% |
D/E | -0.96x |
Interest coverage ratio | -219.50x |
TVGN valuation
P/E | – |
P/S | – |
P/B | -2.19x |
P/CF | -1.30x |
P/FCF | -1.34x |
P/OCF | -1.30x |
PEG | -0.21x |
EV multiple | -0.37x |
About
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology. Its flagship experimental product, TVGN 489, is a precision T cell therapeutic engineered to address critical unmet needs in patients with acute-risk COVID-19, alongside a specific population experiencing long COVID. The company's operations are headquartered in Warren, New Jersey.
Similar securities
Based on sector and market capitalization
Report issue